Clinical trials: Chemotherapy-Induced Amenorrhea
Breast Cancer, Chemotherapy Induced Amenorrhea
Adjuvant Toremifene With or Without Goserrelin in Premenopausal Women With Stage I-IIIA, Hormonal Receptor Positive Breast Cancer Accompanied With or Without Chemotherapy Induced Amenorrhoea
Compare the potential benefits of adjuvant toremifene with or without goserelin in premenopausal women with stage I-IIIA, hormonal receptor positive breast cancer accompanied with or without chemotherapy induced amenorrhoea.
- Conditions
- Breast Cancer, Chemotherapy Induced Amenorrhea, Ovarian Function Suppression
- Trial name
- NCT02132390
- Testing
- Goserelin, Toremifene
- Where
- China
- Volunteers
- 300 people
- Sponsor
- Peking Union Medical College Hospital
Chemotherapy-Induced Amenorrhea
Metabolism, Circadian Rhythms and Ovarian Function
Chemotherapy for cancer, due to its gonadotoxicity, can lead to impaired female fertility, resulting in the occurrence of transient or prolonged chemo-induced amenorrhea (CIA).
- Trial name
- METAB-OV (NCT05007834)
- Where
- France
- Volunteers
- 50 people
- Sponsor
- University Hospital, Lille
Breast Cancer, Perimenopause
AMH Dynamic Changes to Predict Ovarian Reserve in Perimenopausal Breast Cancer
This study is a prospective observational cohort study aimed at developing a clinical model based on dynamic changes in anti-Müllerian hormone (AMH) to predict ovarian reserve in perimenopausal women with hormone…
- Conditions
- Breast Cancer, Perimenopause, Ovarian Reserve
- Trial name
- NCT07497191
- Volunteers
- 300 people
- Sponsor
- Shengjing Hospital
Breast Cancer Nos Premenopausal
Neoadjuvant Chemotherapy for Operable Premenopausal Breast Cancer Patients
The current study is a multicentre, randomized, open (unblended), prospective clinical trial which is sponsored by the researchers.
- Trial name
- NCT01503905
- Testing
- Docetaxel, epirubicin, cyclophosphamide
- Where
- 17 sites in China
- Volunteers
- 600 people
- Sponsor
- Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University